These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 8781142

  • 1. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.
    Ugur O, Kostakğlu L, Güler N, Caner B, Uysal U, Elahi N, Haliloğlu M, Yüksel D, Aras T, Bayhan H, Bekdik C.
    Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Technetium-99m-sestamibi scanning in recurrent medullary thyroid carcinoma.
    Learoyd DL, Roach PJ, Briggs GM, Delbridge LW, Wilmshurst EG, Robinson BG.
    J Nucl Med; 1997 Feb; 38(2):227-30. PubMed ID: 9025742
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings.
    Adams S, Baum RP, Hertel A, Schumm-Draeger PM, Usadel KH, Hör G.
    Eur J Nucl Med; 1998 Sep; 25(9):1277-83. PubMed ID: 9724377
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preparation and clinical evaluation of technetium-99m dimercaptosuccinic acid for tumour scintigraphy.
    Hirano T, Tomiyoshi K, Zhang YJ, Ishida T, Inoue T, Endo K.
    Eur J Nucl Med; 1994 Jan; 21(1):82-5. PubMed ID: 8088289
    [Abstract] [Full Text] [Related]

  • 9. [A comparison of 201Tl and 99mTc-MIBI in the follow-up of differentiated thyroid carcinomas].
    Briele B, Hotze A, Kropp J, Bockisch A, Overbeck B, Grünwald F, Kaiser W, Biersack HJ.
    Nuklearmedizin; 1991 Aug; 30(4):115-24. PubMed ID: 1788076
    [Abstract] [Full Text] [Related]

  • 10. Tc-99m sestamibi and other agents in the detection of metastatic medullary carcinoma of the thyroid.
    Lebouthillier G, Morais J, Picard M, Picard D, Chartrand R, D'Amour P.
    Clin Nucl Med; 1993 Aug; 18(8):657-61. PubMed ID: 8403695
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation.
    Dadparvar S, Chevres A, Tulchinsky M, Krishna-Badrinath L, Khan AS, Slizofski WJ.
    Eur J Nucl Med; 1995 Nov; 22(11):1330-8. PubMed ID: 8575487
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pentavalent Tc-99m DMSA accumulation in a medullary carcinoma of the thyroid.
    Hirano T, Otake H, Watanabe N, Oriuchi N, Fukuda T, Endo K.
    Clin Nucl Med; 1997 May; 22(5):339-40. PubMed ID: 9152545
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.